4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
REgenerative Stem cell therapy for STroke in Europe (RESSTORE)
Date du début: 1 sept. 2015, Date de fin: 31 août 2020,
Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and cognitive impairments, and secondary health problems affecting not only patients but also their families. Building on emerging preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of regenerative cell therapy to improve stroke ...
Voir le projet
29
Participants partenaires
TERMINÉ
Secondary prEvention of CardiovascUlaR disease in the Elderly trial (SECURE)
Date du début: 1 mai 2015, Date de fin: 30 avr. 2020,
While Cardiovascular diseases (CVD) are the main cause of death worldwide, they are responsible for half of all deaths in Europe. The overall ageing of the European population and improving survival of patients with coronary heart disease has created a large population of older adults eligible for secondary prevention. Despite the established efficacy of cardiovascular medications, suboptimal adhe ...
Voir le projet
13
Participants partenaires
TERMINÉ
Combatting Bacterial Resistance in Europe (COMBACTE-NET)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2019,
The emergence of Antibiotic-resistant bacteria (ARB) is a global problem, having recently been elevated to the top three threats identified by the World Health Organisation (WHO), and subject of numerous national and international government activities, including the Trans-Atlantic Task Force on Antimicrobial Resistance established by the US and EU presidencies. The estimated costs of ARB are aro ...
Voir le projet
38
Participants partenaires
TERMINÉ
International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research (INTREALL)
Date du début: 1 oct. 2011, Date de fin: 30 sept. 2016,
Though survival of children with acute lymphoblastic leukaemia (ALL) has improved, relapse remains a leading cause of mortality in childhood cancer. Given the rarity of the disease, only a large international cooperative group can recruit sufficient patients for prospective studies with specific questions in biologic subgroups. Under the umbrella of the I-BFM SG all relevant mainly European study ...
Voir le projet